4.7 Editorial Material

CRISPR-Cas-related technologies in basic and translational liver research

期刊

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2018.11

关键词

-

资金

  1. National Institutes of Health [DP2HL137167, P01HL131471]
  2. American Cancer Society [129056-RSG-16-093]
  3. Lung Cancer Research Foundation
  4. Hyundai Hope on Wheels and ALS Association

向作者/读者索取更多资源

CRISPR-Cas9 has revolutionized biomedical research. Studies in the past few years have achieved notable successes in hepatology, such as correction of genetic disease genes and generation of liver cancer animal models. Where does this technology stand at the frontier of basic and translational liver research?

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据